ArriVent BioPharma, Inc. (AVBP)
(Delayed Data from NSDQ)
$21.73 USD
-1.12 (-4.90%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $21.71 -0.02 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.65 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 16.67% |
ABR | 1.00 |
Earnings ESP
|
16.60% |
---|---|
Current Year | -2.91 |
Next Year | -3.13 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.65 | -0.79 | -2.91 | -3.13 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.54 | -0.57 | -2.39 | -2.65 |
High Estimate | -0.54 | -0.57 | -2.39 | -2.53 |
Low Estimate | -0.76 | -1.22 | -3.95 | -4.22 |
Year ago EPS | NA | NA | -32.38 | -2.91 |
Year over Year Growth Est. | NA | NA | 91.01% | -7.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.65 | -0.79 | -2.91 | -3.13 |
7 Days Ago | -0.65 | -0.79 | -2.91 | -3.13 |
30 Days Ago | -0.68 | -0.86 | -3.07 | -3.13 |
60 Days Ago | -0.68 | -0.86 | -3.07 | -3.13 |
90 Days Ago | -0.58 | -0.75 | -2.71 | -2.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.57 | -2.41 | -3.11 |
Zacks Consensus Estimate | -0.65 | -0.79 | -2.91 | -3.13 |
Earnings ESP | 16.60% | 27.62% | 17.11% | 0.56% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | NA | NA | NA | NA |
Estimate | -0.84 | NA | NA | NA | NA |
Difference | 0.14 | NA | NA | NA | 0.14 |
Surprise | 16.67% | NA | NA | NA | 16.67% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more